TY - JOUR AU - Eichler, H. G. AU - Abadie, E. AU - Baker, M. AU - Rasi, G. PY - 2012 DA - 2012// TI - Fifty years after thalidomide; what role for drug regulators? JO - Br J Clin Pharmacol VL - 74 UR - https://doi.org/10.1111/j.1365-2125.2012.04255.x DO - 10.1111/j.1365-2125.2012.04255.x ID - Eichler2012 ER - TY - JOUR AU - Eichler, H. G. AU - Bloechl-Daum, B. AU - Brasseur, D. AU - Breckenridge, A. AU - Leufkens, H. AU - Raine, J. PY - 2013 DA - 2013// TI - The risks of risk aversion in drug regulation JO - Nat Rev Drug Discov VL - 12 UR - https://doi.org/10.1038/nrd4129 DO - 10.1038/nrd4129 ID - Eichler2013 ER - TY - JOUR AU - Chakradhar, S. PY - 2015 DA - 2015// TI - Training on trials: patients taught the language of drug development JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm0315-209 DO - 10.1038/nm0315-209 ID - Chakradhar2015 ER - TY - JOUR AU - Pushparajah, D. S. AU - Geissler, J. AU - Westergaard, N. PY - 2015 DA - 2015// TI - EUPATI: collaboration between patients, academia and industry to champion the infromed patient in the research and development of medicines JO - J Med DevSci VL - 1 ID - Pushparajah2015 ER - TY - JOUR AU - Barry, M. J. AU - Edgman-Levitan, S. PY - 2012 DA - 2012// TI - Shared decision making--pinnacle of patient-centered care JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMp1109283 DO - 10.1056/NEJMp1109283 ID - Barry2012 ER - TY - JOUR AU - Stacey, D. AU - Legare, F. AU - Col, N. F. AU - Bennett, C. L. AU - Barry, M. J. AU - Eden, K. B. PY - 2014 DA - 2014// TI - Decision aids for people facing health treatment or screening decisions JO - Cochrane Database Syst Rev VL - 1 ID - Stacey2014 ER - TY - JOUR AU - Minvielle, E. AU - Waelli, M. AU - Sicotte, C. AU - Kimberly, J. R. PY - 2014 DA - 2014// TI - Managing customization in health care: a framework derived from the services sector literature JO - Health Policy VL - 117 UR - https://doi.org/10.1016/j.healthpol.2014.04.005 DO - 10.1016/j.healthpol.2014.04.005 ID - Minvielle2014 ER - TY - JOUR AU - Eaton, S. AU - Collins, A. AU - Coulter, A. AU - Elwyn, G. AU - Grazin, N. AU - Roberts, S. PY - 2012 DA - 2012// TI - Putting patients first JO - BMJ VL - 344 UR - https://doi.org/10.1136/bmj.e2006 DO - 10.1136/bmj.e2006 ID - Eaton2012 ER - TY - BOOK AU - Coulter, A. AU - Collins, A. PY - 2011 DA - 2011// TI - Making shared decision-making a reality: no decision about me, without me PB - The King’s Fund CY - London ID - Coulter2011 ER - TY - STD TI - Health Technology Assessment international (HTAi). Completing a Patient Group Submission Template: Guidance for Patient Organisations for Health Technology Assessment and Appraisal of Medicines. 2015. Health Technology Assessment international (HTAi). ID - ref10 ER - TY - BOOK PY - 2010 DA - 2010// TI - Road map to 2015. The european medicines Agency’s contribution to science, medicines and health PB - European Medicines Agency (EMA) CY - London ID - ref11 ER - TY - BOOK PY - 2014 DA - 2014// TI - Incorporating patients’ views during evaluation of benefit-risk by the EMA scientific committees. EMA/413422/2013 PB - European Medicines Agency (EMA) CY - London ID - ref12 ER - TY - BOOK PY - 2014 DA - 2014// TI - Pilot phase to involve patients in benefit/risk discussions at CHMP meetings. EMA/372554/2014 PB - European Medicines Agency (EMA) CY - London ID - ref13 ER - TY - BOOK PY - 2011 DA - 2011// TI - Final CHMP work programme for 2011–2013 . EMA/CHMP/65166/2011 PB - European Medicines Agency (EMA) CY - London ID - ref14 ER - TY - BOOK PY - 2013 DA - 2013// TI - Structured approach to benefit-risk assessment in drug regulatory decision-making. Draft PDUFA V implementation plan PB - Food and Drug Administration (FDA) CY - Washington ID - ref15 ER - TY - BOOK PY - 2015 DA - 2015// TI - Prescription drug user Fee Act patient-focused drug development; announcement of disease areas for meetings conducted in fiscal years 2013–2015. Vol. 78, No. 70. 11-4-2013 PB - Federal Register CY - Washington ID - ref16 ER - TY - BOOK PY - 2014 DA - 2014// TI - Regulatory and methodological standards to improve benefit-risk evaluation of medicines. Workshop report PB - European Medicines Agency (EMA) CY - London ID - ref17 ER - TY - BOOK PY - 2012 DA - 2012// TI - New medicines for serious conditions: weighing the risks and benefits. The verdict of a jury of patients PB - Genetic Alliance UK CY - London ID - ref18 ER - TY - BOOK PY - 2014 DA - 2014// TI - The Duchenne community imperatives for the guidance for industry on Duchenne muscular dystrophy: developing drugs for treatment over the spectrum of disease PB - Parent Project Muscular Dystrophy CY - Hackensak ID - ref19 ER - TY - BOOK PY - 2014 DA - 2014// TI - Report: complex issues in developing drugs and biological products for rare diseases and accelerating the development of therapies for pediatric rare diseases, including strategic plan: accelerating the development of therapies for pediatric rare diseases PB - Food and Drug Administration (FDA) CY - Washington ID - ref20 ER - TY - JOUR AU - Bekker-Grob, E. W. AU - Ryan, M. AU - Gerard, K. PY - 2012 DA - 2012// TI - Discrete choice experiments in health economics: a review of the literature JO - Health Econ VL - 21 UR - https://doi.org/10.1002/hec.1697 DO - 10.1002/hec.1697 ID - Bekker-Grob2012 ER - TY - JOUR AU - Bridges, J. F. AU - Hauber, A. B. AU - Marshall, D. AU - Lloyd, A. AU - Prosser, L. A. AU - Regier, D. A. PY - 2011 DA - 2011// TI - Conjoint analysis applications in health--a checklist: a report of the ISPOR good research practices for conjoint analysis task force JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2010.11.013 DO - 10.1016/j.jval.2010.11.013 ID - Bridges2011 ER - TY - JOUR AU - Ryan, M. AU - Gerard, K. PY - 2003 DA - 2003// TI - Using discrete choice experiments to value health care programmes: current practice and future research reflections JO - Appl Health Econ Health Policy VL - 2 ID - Ryan2003 ER - TY - JOUR AU - Marshall, D. AU - Bridges, J. F. AU - Hauber, B. AU - Cameron, R. AU - Donnalley, L. AU - Fyie, K. PY - 2010 DA - 2010// TI - Conjoint analysis applications in health - How are studies being designed and reported?: an update on current practice in the published literature between 2005 and 2008 JO - Patient VL - 3 UR - https://doi.org/10.2165/11539650-000000000-00000 DO - 10.2165/11539650-000000000-00000 ID - Marshall2010 ER - TY - JOUR AU - Ryan, M. AU - Farrar, S. PY - 2000 DA - 2000// TI - Using conjoint analysis to elicit preferences for health care JO - BMJ VL - 320 UR - https://doi.org/10.1136/bmj.320.7248.1530 DO - 10.1136/bmj.320.7248.1530 ID - Ryan2000 ER - TY - JOUR AU - Johnson, F. R. PY - 2008 DA - 2008// TI - Why not ask?: measuring patient preferences for healthcare decision making JO - Patient VL - 1 UR - https://doi.org/10.2165/1312067-200801040-00003 DO - 10.2165/1312067-200801040-00003 ID - Johnson2008 ER - TY - JOUR AU - Lancsar, E. AU - Louviere, J. PY - 2008 DA - 2008// TI - Conducting discrete choice experiments to inform healthcare decision making: a user’s guide JO - Pharmacoecon VL - 26 UR - https://doi.org/10.2165/00019053-200826080-00004 DO - 10.2165/00019053-200826080-00004 ID - Lancsar2008 ER - TY - JOUR AU - Bridges, J. F. AU - Kinter, E. T. AU - Kidane, L. AU - Heinzen, R. R. AU - McCormick, C. PY - 2008 DA - 2008// TI - Things are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982–2007 JO - Patient VL - 1 UR - https://doi.org/10.2165/1312067-200801040-00009 DO - 10.2165/1312067-200801040-00009 ID - Bridges2008 ER - TY - JOUR AU - Harrison, M. AU - Rigby, D. AU - Vass, C. AU - Flynn, T. AU - Louviere, J. AU - Payne, K. PY - 2014 DA - 2014// TI - Risk as an attribute in discrete choice experiments: a systematic review of the literature JO - Patient VL - 7 UR - https://doi.org/10.1007/s40271-014-0048-1 DO - 10.1007/s40271-014-0048-1 ID - Harrison2014 ER - TY - JOUR AU - Hauber, A. B. AU - Fairchild, A. O. AU - Reed, J. PY - 2013 DA - 2013// TI - Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature JO - Appl Health Econ Health Policy VL - 11 UR - https://doi.org/10.1007/s40258-013-0028-y DO - 10.1007/s40258-013-0028-y ID - Hauber2013 ER - TY - BOOK AU - Train, K. PY - 2009 DA - 2009// TI - Discrete choice methods with simulation PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511805271 DO - 10.1017/CBO9780511805271 ID - Train2009 ER - TY - JOUR AU - Hensher, D. A. AU - Greene, W. H. PY - 2003 DA - 2003// TI - The Mixed Logit model: the state of practice JO - Transportation VL - 30 UR - https://doi.org/10.1023/A:1022558715350 DO - 10.1023/A:1022558715350 ID - Hensher2003 ER - TY - BOOK AU - Ryan, M. AU - Gerard, K. AU - Amaya-Amaya, M. PY - 2008 DA - 2008// TI - Using discrete choice experiments to value health and health care PB - Springer CY - Dordrecht UR - https://doi.org/10.1007/978-1-4020-5753-3 DO - 10.1007/978-1-4020-5753-3 ID - Ryan2008 ER - TY - BOOK AU - Louviere, J. AU - Hensher, D. AU - Swait, J. PY - 2000 DA - 2000// TI - Stated choice methods: analysis and applications PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511753831 DO - 10.1017/CBO9780511753831 ID - Louviere2000 ER - TY - BOOK AU - Hensher, D. A. AU - Rose, J. AU - Greene, W. PY - 2005 DA - 2005// TI - Applied choice analysis: a primer PB - Cambridge University Press CY - Cambridge UR - https://doi.org/10.1017/CBO9780511610356 DO - 10.1017/CBO9780511610356 ID - Hensher2005 ER - TY - JOUR AU - Pickard, A. S. AU - Knight, S. J. PY - 2005 DA - 2005// TI - Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives JO - Med Care VL - 43 UR - https://doi.org/10.1097/01.mlr.0000160419.27642.a8 DO - 10.1097/01.mlr.0000160419.27642.a8 ID - Pickard2005 ER - TY - JOUR AU - Ustun, T. B. AU - Chatterji, S. AU - Kostanjsek, N. AU - Rehm, J. AU - Kennedy, C. AU - Epping-Jordan, J. PY - 2010 DA - 2010// TI - Developing the world health organization disability assessment schedule 2.0 JO - Bull World Health Organ VL - 88 UR - https://doi.org/10.2471/BLT.09.067231 DO - 10.2471/BLT.09.067231 ID - Ustun2010 ER - TY - BOOK AU - Ustun, T. B. AU - Kastanjsek, N. AU - Chatterji, S. AU - Rehm, J. PY - 2010 DA - 2010// TI - Measuring health and disability. Manual for the WHO disability assessment schedule. WHODAS 2.0 PB - World Health Organisation CY - Geneva ID - Ustun2010 ER - TY - JOUR AU - Bliemer, M. C. J. AU - Rose, J. M. PY - 2010 DA - 2010// TI - Construction of experimental designs for mixed logit models allowing for correlation across choice observations JO - Transp Res B VL - 44 UR - https://doi.org/10.1016/j.trb.2009.12.004 DO - 10.1016/j.trb.2009.12.004 ID - Bliemer2010 ER - TY - JOUR AU - Kessels, R. AU - Goos, P. AU - Vandebroek, M. PY - 2006 DA - 2006// TI - A comparison of criteria to design efficient choice experiments JO - J Mark Res VL - 43 UR - https://doi.org/10.1509/jmkr.43.3.409 DO - 10.1509/jmkr.43.3.409 ID - Kessels2006 ER - TY - BOOK AU - Orme, J. PY - 2006 DA - 2006// TI - Getting started with conjoint analysis: strategies for product design and pricing research PB - Research Publishers LLC CY - Madison ID - Orme2006 ER - TY - JOUR AU - Yu, J. AU - Goos, P. AU - Vandebroek, M. PY - 2009 DA - 2009// TI - Efficient conjoint choice designs in the presence of respondent heterogeneity JO - Mark Sci VL - 28 UR - https://doi.org/10.1287/mksc.1080.0386 DO - 10.1287/mksc.1080.0386 ID - Yu2009 ER - TY - JOUR AU - Yu, J. AU - Goos, P. AU - Vandebroek, M. PY - 2011 DA - 2011// TI - Individually adapted sequential Bayesian conjoint-choice designs in the presence of consumer heterogeneity JO - Int J Res Mark VL - 28 UR - https://doi.org/10.1016/j.ijresmar.2011.06.002 DO - 10.1016/j.ijresmar.2011.06.002 ID - Yu2011 ER - TY - JOUR AU - Yu, J. AU - Goos, P. AU - Vandebroek, M. PY - 2012 DA - 2012// TI - A comparison of different Bayesian design criteria for setting up stated preference studies JO - Transp Res B VL - 46 UR - https://doi.org/10.1016/j.trb.2012.01.007 DO - 10.1016/j.trb.2012.01.007 ID - Yu2012 ER - TY - JOUR AU - Andrews, G. AU - Kemp, A. AU - Sunderland, M. AU - Von, K. M. AU - Ustun, T. B. PY - 2009 DA - 2009// TI - Normative data for the 12 item WHO disability assessment schedule 2.0 JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0008343 DO - 10.1371/journal.pone.0008343 ID - Andrews2009 ER - TY - JOUR AU - Kakkis, E. D. AU - O’Donovan, M. AU - Cox, G. AU - Hayes, M. AU - Goodsaid, F. AU - Tandon, P. K. PY - 2015 DA - 2015// TI - Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints JO - Orphanet J Rare Dis VL - 10 UR - https://doi.org/10.1186/s13023-014-0195-4 DO - 10.1186/s13023-014-0195-4 ID - Kakkis2015 ER - TY - JOUR AU - Schork, N. J. PY - 2015 DA - 2015// TI - Personalized medicine: time for one-person trials JO - Nature VL - 520 UR - https://doi.org/10.1038/520609a DO - 10.1038/520609a ID - Schork2015 ER - TY - STD TI - US Department of Health and Human Services FaDAF. Paving the Way for Personalized Medicine. FDA’s Role in a New Era of Medical Product Development. Washington D.C., USA: U.S. Food and Drug Administration; 2013. ID - ref48 ER - TY - BOOK PY - 2015 DA - 2015// TI - Letter to the U.S. Senate HELP Committee in support of the Advancing Targeted Therapies for Rare Diseases Act ID - ref49 ER - TY - BOOK AU - Douglas, M. AU - Wildavsky, A. PY - 1982 DA - 1982// TI - Risk and culture: an essay on the selection of technical and environmental dangers PB - Berkeley: University of California Press CY - Berkeley ID - Douglas1982 ER - TY - BOOK AU - Krimsky, S. AU - Golding, D. PY - 1992 DA - 1992// TI - Social theories of risk PB - Praeger-Greenwood CY - Westport ID - Krimsky1992 ER - TY - JOUR AU - Douglas, M. PY - 1990 DA - 1990// TI - Risk as a forensic resource JO - Daedalus Proc Am Acad Arts Sci VL - 119 ID - Douglas1990 ER - TY - JOUR AU - Kesselheim, A. S. AU - McGraw, S. AU - Thompson, L. AU - O’Keefe, K. AU - Gagne, J. J. PY - 2015 DA - 2015// TI - Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates JO - Patient VL - 8 UR - https://doi.org/10.1007/s40271-014-0096-6 DO - 10.1007/s40271-014-0096-6 ID - Kesselheim2015 ER - TY - JOUR AU - Peay, H. L. AU - Hollin, I. AU - Fischer, R. AU - Bridges, J. F. PY - 2014 DA - 2014// TI - A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy JO - Clin Ther VL - 36 UR - https://doi.org/10.1016/j.clinthera.2014.04.011 DO - 10.1016/j.clinthera.2014.04.011 ID - Peay2014 ER - TY - BOOK AU - Woodcock, J. PY - 2015 DA - 2015// TI - PDUFA V Clinical Outcome Assessments Public workshop ID - Woodcock2015 ER - TY - JOUR AU - Walton, M. K. AU - Powers, J. H. AU - Hobart, J. AU - Patrick, D. AU - Marquis, P. AU - Vamvakas, S. PY - 2015 DA - 2015// TI - Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment - emerging good practices for outcomes research task force JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.08.006 DO - 10.1016/j.jval.2015.08.006 ID - Walton2015 ER - TY - JOUR AU - Frank, L. AU - Basch, E. AU - Selby, J. V. PY - 2014 DA - 2014// TI - The PCORI perspective on patient-centered outcomes research JO - JAMA VL - 312 UR - https://doi.org/10.1001/jama.2014.11100 DO - 10.1001/jama.2014.11100 ID - Frank2014 ER - TY - JOUR AU - Bartlett, S. J. AU - Barnes, T. AU - McIvor, R. A. PY - 2014 DA - 2014// TI - Integrating patients into meaningful real-world research JO - Ann Am Thorac Soc VL - 11 UR - https://doi.org/10.1513/AnnalsATS.201309-327RM DO - 10.1513/AnnalsATS.201309-327RM ID - Bartlett2014 ER - TY - STD TI - International Rare Diseases Research Consortium (IRDiRC). Preparatory Document for Workshop on Patient-Centred Outcome Measures Initiatives in the Field of Rare Diseases. 2-10-2015. ID - ref59 ER -